Diacomit (stiripentol)
Alan Pharmaceuticals is the Marketing Authorisation Holder for Diacomit (stiripentol) in Great Britain.
It is available in the following presentations:
- DIACOMIT (stiripentol) 250mg capsules, for oral use
- DIACOMIT (stiripentol) 250mg powder, for oral suspension
- DIACOMIT (stiripentol) 500mg capsules, for oral use
- DIACOMIT (stiripentol) 500mg powder, for oral suspension
Diacomit (stiripentol) Product Information
The Patient Information Leaflet and Summary of Product Characteristics for GB licensed packs can be accessed here.
The link will take you to the electronic Medicines Compendium (eMC) website which is a non-Alan Pharmaceuticals website. Alan Pharmaceuticals does not recommend, endorse or accept liability for sites controlled by third-parties.
The Patient Information Leaflet and Summary of Product Characteristics for EMA licensed packs can be accessed here.
This link will take you to the European Medicines Agency (EMA) website which is a non-Alan Pharmaceuticals website. Alan Pharmaceuticals does not recommend, endorse or accept liability for sites controlled by third- parties.
European Public Assessment Report
Please see the European Public Assessment Report here.
This link will take you to the European Medicines Agency (EMA) website which is a non-Alan Pharmaceuticals website. Alan Pharmaceuticals does not recommend, endorse or accept liability for sites controlled by third- parties.
Diacomit (stiripentol) Adverse Drug Reaction Reporting and Medical Information
You can find the contact details on our Contact Us page.
|